Diagnostik affektiver Störungen im DSM-5: Neuerungen und Kontroversen

Lernziele

Der vorliegende CME-Beitrag zur Diagnostik affektiver Störungen im DSM-5 informiert über:

• Entwicklung des DSM

• Kontroverse um das DSM-5

• Wichtige Änderungen im DSM-5 und deren Begründung

  • Wegfall der Ausnahme für Trauerfälle

  • Anhaltende depressive Störung

  • Prämenstruelle dysphorische Störung

  • Zusatzcodierung „Ängstliche Belastung“ für Manie und Depression

  • Bipolare Störung

• Literatur

• 1 American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-5. 5 ed. Arlington, VA: American Psychiatric Association; 2013
• 2 Frances A. DSM-5 Is A Guide, Not A Bible—Simply Ignore Its 10 Worst Changes. Blog 2012 Im Internet: http://www.psychiatrictimes.com/blogs/dsm-5/dsm-5-guide-not-bible%E2%80%94simply-ignore-its-10-worst-changes Stand: 06.10.2014
• 3 DGPPN. Die Position der DGPPN. PSYCHE IM FOKUS 2013; 2: 10
• 4 American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-IV. Washington, DC: American Psychiatric Association; 1994
• 5 Wakefield JC, First MB. Validity of the bereavement exclusion to major depression: does the empirical evidence support the proposal to eliminate the exclusion in DSM-5?. World Psychiatry 2012; 11: 3-10
• 6 Zisook S, Kendler KS. Is bereavement-related depression different than non-bereavement-related depression?. Psychol Med 2007; 37: 779-794
• 7 Mojtabai R. Bereavement-related depressive episodes: characteristics, 3-year course, and implications for the DSM-5. Arch Gen Psychiatry 2011; 68: 920-928
• 8 Wakefield JC, Schmitz MF. Recurrence of depression after bereavement-related depression: evidence for the validity of DSM-IV bereavement exclusion from the Epidemiologic Catchment Area Study. J Nerv Ment Dis 2012; 200: 480-485
• 9 Shear MK, Simon N, Wall M et al. Complicated grief and related bereavement issues for DSM-5. Depress Anxiety 2011; 28: 103-117
• 10 Zisook S, Shear K. Grief and bereavement: what psychiatrists need to know. World Psychiatry 2009; 8: 67-74
• 11 Maj M. Bereavement-related depression in the DSM-5 and ICD-11. World Psychiatry 2012; 11: 1-2
• 12 Fava M. Diagnosis and definition of treatment-resistant depression. Biol Psychiatry 2003; 53: 649-659
• 13 Klein JP, Steinlechner S, Sipos V et al. Psychotherapy of chronic depression with cognitive behavioral analysis system of psychotherapy (CBASP). Psychother Psychosom Med Psychol 2011; 61: 526
• 14 Klein JP, Belz M. Psychotherapie Chronischer Depression. Praxisleitfaden CBASP. Göttingen: Hogrefe; 2014
• 15 Satyanarayana S, Enns MW, Cox BJ et al. Prevalence and correlates of chronic depression in the canadian community health survey: mental health and well-being. Can J Psychiatry 2009; 54: 389-398
• 16 Murphy JA, Byrne GJ. Prevalence and correlates of the proposed DSM-5 diagnosis of Chronic Depressive Disorder. J Affect Disord 2012; 139: 172-180
• 17 Blanco C, Okuda M, Markowitz JC et al. The epidemiology of chronic major depressive disorder and dysthymic disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry 2010; 71: 1645-1656
• 18 Klein DN, Shankman SA, Rose S. Ten-year prospective follow-up study of the naturalistic course of dysthymic disorder and double depression. Am J Psychiatry 2006; 163: 872-880
• 19 Cuijpers P, van Straten A, Schuurmans J et al. Psychotherapy for chronic major depression and dysthymia: a meta-analysis. Clin Psychol Rev 2009; 30: 51-62
• 20 Keller MB, McCullough JP, Klein DN et al. A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. N Engl J Med 2000; 342: 1462-1470
• 21 McCullough JP. Treatment for chronic depression: cognitive behavioral analysis system of psychotherapy (CBASP). New York: The Guilford Press; 2000
• 22 Epperson CN, Steiner M, Hartlage SA et al. Premenstrual dysphoric disorder: evidence for a new category for DSM-5. Am J Psychiatry 2012; 169: 465-475
• 23 Marjoribanks J, Brown J, O'Brien PM et al. Selective serotonin reuptake inhibitors for premenstrual syndrome. Cochrane Database Syst Rev 2013; 6: CD001396
• 24 Wikander I, Sundblad C, Andersch B et al. Citalopram in premenstrual dysphoria: is intermittent treatment during luteal phases more effective than continuous medication throughout the menstrual cycle?. J Clin Psychopharmacol 1998; 18: 390-398
• 25 Fava M, Rush AJ, Alpert JE et al. Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report. Am J Psychiatry 2008; 165: 342-351
• 26 Severus E, Bauer M. Bipolar disorders in DSM-5. Nervenarzt 2014; 85: 543-547
• 27 Angst J. Bipolar disorders in DSM-5: strengths, problems and perspectives. Int J Bipolar Disord 2013; 1: 12
• 28 Correa R, Akiskal H, Gilmer W et al. Is unrecognized bipolar disorder a frequent contributor to apparent treatment resistant depression?. J Affect Disord 2010; 127: 10-18
• 29 Akiskal HS, Pinto O. The evolving bipolar spectrum. Prototypes I, II, III, and IV. Psychiatr Clin North Am 1999; 22: 517-534